Percentage of ultrasound images which are clinically adequate for treatment set-up in the judgment of the treating physician
| Group | Value | 95% CI |
|---|---|---|
| Diagnostic (KV-CBCT, Ultrasound-guided Radiation Therapy) | 100 |
Last reviewed · How we verify
KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer
NA trial testing Cone-Beam Computed Tomography in Adult Liver Carcinoma in 30 participants. Completed in 14 December 2019.
| Lead sponsor | Case Comprehensive Cancer Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 30 |
| Start date | 22 September 2015 |
| Primary completion | 14 December 2019 |
| Estimated completion | 14 December 2019 |
| Sites | 1 location across United States |
Case Comprehensive Cancer Center — full company profile →
19 and older, any sex, with Adult Liver Carcinoma or Malignant Pancreatic Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Percentage of ultrasound images which are clinically adequate for treatment set-up in the judgment of the treating physician
| Group | Value | 95% CI |
|---|---|---|
| Diagnostic (KV-CBCT, Ultrasound-guided Radiation Therapy) | 100 |
Proportion of participants able to have the ultrasound probe attached during the entire treatment course
| Group | Value | 95% CI |
|---|---|---|
| Diagnostic (KV-CBCT, Ultrasound-guided Radiation Therapy) | 29 |
Quality of plans for patients not affected in the presence of the ultrasound probe, defined as no more than a 2% decrease in tumor coverage, and also no more than a 2% increase in the dose to the most critical normal tissue for that tumor location
| Group | Value | 95% CI |
|---|---|---|
| Diagnostic (KV-CBCT, Ultrasound-guided Radiation Therapy) | 100 |
This clinical trial studies if kilo-voltage cone beam computed tomography (KV-CBCT) and ultrasound imaging works in guiding radiation therapy in patients with prostate, liver, or pancreatic cancer. Computer systems, such as KV-CBCT and ultrasound imaging, allow doctors to create a 3-dimensional picture of the tumor may help in planning radiation therapy and may result in more tumor cells being killed.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Trials testing the same drug.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02337465.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing